Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03386383
Other study ID # LCCC1709
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 28, 2018
Est. completion date March 25, 2019

Study information

Verified date May 2023
Source UNC Lineberger Comprehensive Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to examine the feasibility, acceptability, and gather preliminary data on outcomes of a 3-month mHealth intervention to promote physical activity among adolescent and young adult (AYA) cancer survivors compared to a delayed intervention control group.


Description:

Adolescent and young adult (AYA) survivors are not meeting recommended physical activity guidelines for cancer survivors, and few interventions to date have focused specifically on promoting physical activity among AYAs or capitalized on new technologies to deliver them. This is a pilot randomized controlled trial (RCT) to examine the feasibility, acceptability, and gather preliminary data on outcomes of a 3-month mHealth intervention to promote PA among AYA survivors compared to a delayed intervention control group. This project will focus on how to best integrate self-monitoring with wearable trackers, increase self-efficacy, enhance autonomous motivation, and promote social support in a mobile health behavioral intervention that promotes moderate-to-vigorous intensity physical activity (MVPA) among AYA survivors. Participants will be AYA cancer survivors (N=60), diagnosed at age 15 or older and currently age 18-39. AYA cancer survivors will be recruited from the three comprehensive cancer centers in North Carolina to participate in this study. The behavioral intervention will consist of an activity tracker, Facebook group, weekly email lessons, and weekly tailored feedback emails. Assessments of objectively-measured physical activity and other outcomes will be completed at baseline, 3, and 6 months.


Recruitment information / eligibility

Status Completed
Enrollment 64
Est. completion date March 25, 2019
Est. primary completion date March 25, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 39 Years
Eligibility Inclusion Criteria: - Diagnosed with cancer (excluding basal cell skin cancer) at age 15 or older - Currently age 18-39 - Are 0 to 10 years post active cancer treatment (i.e., current hormonal treatments or maintenance therapies are permissible) - Able to speak, read and write English - Have access to the Internet and computer on at least a weekly basis - Possession and usage of an Internet e-mail address or willingness to sign up for a free email account - Have active Facebook account - Willing to be randomized to either arm Exclusion Criteria: - History of heart attack or stroke within past 6 months - Untreated hypertension, hyperlipidemia, or diabetes, unless permission is provided by their health care provider - Have a pre-existing medical condition(s) or contraindications that preclude adherence to an unsupervised exercise program, including cardiovascular disease, heart failure, pulmonary conditions, renal disease, and severe orthopedic conditions - Are already adhering to the American Cancer Society's recommendation of =150 minutes of moderate-intensity exercise per week (<150 minutes/week) - Current participation in another physical activity or weight control program - Currently pregnant, pregnant within the past 6 months, or planning to become pregnant within the next 6 months - Plans for major surgery (e.g., breast reconstruction) during the study time frame

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Intervention
Individual session, physical activity tracker, online intervention

Locations

Country Name City State
United States University of North Carolina at Chapel Hill Chapel Hill North Carolina
United States Duke University Medical Center Durham North Carolina
United States Wake Forest University School of Medicine Winston-Salem North Carolina

Sponsors (2)

Lead Sponsor Collaborator
UNC Lineberger Comprehensive Cancer Center Wake Forest University Health Sciences

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Posttraumatic growth Change in posttraumatic growth, as measured by the Short Form of the Posttraumatic Growth Inventory, from baseline to 3 months, and 3 months to 6 months. Responses range from 0 to 5 and yield an overall score and subscale scores for relating to others, new possibilities, personal strength, spiritual change, and appreciation of life. Items are summed, with higher scores reflecting more positive change (i.e., posttraumatic growth). Baseline, 3 months, 6 months
Other Positive psychosocial illness impact Changes in positive psychosocial impact of illness, as measured by the PROMIS Psychosocial Illness Impact - Positive (4a), from baseline to 3 months, and 3 months to 6 months. Responses to the 4-item short from range from 1 to 5. Items are summed, with higher scores reflecting more positive psychosocial impact. Baseline, 3 months, 6 months
Other Negative psychosocial illness impact Changes in positive psychosocial impact of illness, as measured by the PROMIS Psychosocial Illness Impact - Negative (4a), from baseline to 3 months, and 3 months to 6 months. Responses to the 4-item short from range from 1 to 5. Items are summed, with higher scores reflecting more negative psychosocial impact. Baseline, 3 months, 6 months
Other Positive affect Changes in positive affect, as measured by the NIH Toolbox Positive Affect Short Form, from baseline to 3 months, and 3 months to 6 months. Baseline, 3 months, 6 months
Other Social network orientation Changes in positive affect, as measured by the Network Orientation Scale, from baseline to 3 months, and 3 months to 6 months. Responses to 20 items range from 1 to 4. Items are summed (range: 20 to 80), with higher scores representing a more negative social network orientation. Baseline, 3 months, 6 months
Primary Accrual rate Number of participants who agreed to participate divided by the number of months of recruitment. Through completion of study enrollment, an average of 6 months.
Primary Participation rate Percentage of eligible participants who agreed to participate. Through completion of study enrollment, an average of 6 months.
Primary Retention rate at 3 months Number of intervention participants who completed 3-month measures divided by the number who consented to participate. 3 months
Secondary Retention rate at 6 months Number of intervention participants who completed 6-month measures divided by the number randomized to the intervention group. 6 months
Secondary Satisfaction with intervention Ratings of satisfaction with the intervention, as measured by satisfaction questionnaire. 6 months
Secondary Adherence to physical activity monitoring Number of days physical activity tracked, as measured by Fitbit. Through study completion, 6 months
Secondary Physical activity: objective Change in objective levels of physical activity, as measured by accelerometry (Actigraph), from baseline to 3 months, and 3 months to 6 months. Baseline, 3 months, 6 months
Secondary Physical activity: self-report Change in self-report levels of physical activity, as measured by the Godin Leisure Time Exercise Questionnaire, from baseline to 3 months, and 3 months to 6 months. Baseline, 3 months, 6 months
Secondary Sedentary behavior: self-report Change in self-report levels of sedentary behavior, as measured by the Marshall Sitting Time Questionnaire, from baseline to 3 months, and 3 months to 6 months. Baseline, 3 months, 6 months
Secondary Weight Change in self-reported weight, from baseline to 3 months, and 3 months to 6 months. Baseline, 3 months, 6 months
Secondary Intrinsic motivation Change in intrinsic motivation, as measured by the intrinsic motivation subscale of the Treatment Self-Regulation Questionnaire for Exercise, from baseline to 3 months, and 3 months to 6 months. Responses to four items comprising intrinsic motivation subscale are averaged to yield a score from 1 to 7, with higher values representing higher intrinsic motivation. Baseline, 3 months, 6 months
Secondary Self-efficacy for exercise Change in self-efficacy for exercise, as measured by the Self-Efficacy and Exercise Habits Survey, from baseline to 3 months, and 3 months to 6 months. Responses for two subscales (Sticking to it, Making time for exercise) are averaged to yield a score from 1 to 5, with higher values representing higher self-efficacy for exercise. Baseline, 3 months, 6 months
Secondary Social support for exercise Change in social support for exercise, as measured by the Social Support for Exercise Survey, from baseline to 3 months, and 3 months to 6 months. Responses for three factors (Family participation, Friend participation, Friends on social networking sites participation), ranging from 1 to 5, are summed, with higher values representing higher social support for exercise. Baseline, 3 months, 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases